Department of Respiratory Disease, The Hospital Affiliated to Jiangnan University, Wuxi, China,
Wuxi Medical College of Jiangnan University, Wuxi, China.
Int Arch Allergy Immunol. 2021;182(1):53-64. doi: 10.1159/000508330. Epub 2020 Oct 20.
As an ancient Gram-negative bacterium, Helicobacter pylori has settled in human stomach. Eradicating H. pylori increases the morbidities of asthma and other allergic diseases. Therefore, H. pylori might play a protective role against asthma. The "disappearing microbiota" hypothesis suggests that the absence of certain types of the ancestral microbiota could change the development of immunology, metabolism, and cognitive ability in our early life, contributing to the development of some diseases. And the Hygiene Hypothesis links early environmental and microbial exposure to the prevalence of atopic allergies and asthma. Exposure to the environment and microbes can influence the growing immune system and protect subsequent immune-mediated diseases. H. pylori can inhibit allergic asthma by regulating the ratio of helper T cells 1/2 (Th1/Th2), Th17/regulatory T cells (Tregs), etc. H. pylori can also target dendritic cells to promote immune tolerance and enhance the protective effect on allergic asthma, and this effect relies on highly suppressed Tregs. The remote regulation of lung immune function by H. pylori is consistent with the gut-lung axis theory. Perhaps, H. pylori also protects against asthma by altering levels of stomach hormones, affecting the autonomic nervous system and lowering the expression of heat shock protein 70. Therapeutic products from H. pylori may be used to prevent and treat asthma. This paper reviews the possible protective influence of H. pylori on allergic asthma and the possible application of H. pylori in treating asthma.
作为一种古老的革兰氏阴性细菌,幽门螺杆菌已定居在人类的胃中。根除幽门螺杆菌会增加哮喘和其他过敏性疾病的发病率。因此,幽门螺杆菌可能对哮喘起到保护作用。“消失的微生物群”假说表明,某些类型的原始微生物群的缺失可能会改变我们早期生活中免疫学、代谢和认知能力的发展,从而导致某些疾病的发生。而卫生假说则将早期的环境和微生物暴露与特应性过敏和哮喘的流行联系起来。暴露于环境和微生物会影响正在发育的免疫系统,并保护随后发生的免疫介导性疾病。幽门螺杆菌可以通过调节辅助性 T 细胞 1/2(Th1/Th2)、Th17/调节性 T 细胞(Tregs)等的比例来抑制过敏性哮喘。幽门螺杆菌还可以靶向树突状细胞,促进免疫耐受,增强对过敏性哮喘的保护作用,而这种作用依赖于高度抑制的 Tregs。幽门螺杆菌对肺部免疫功能的远程调节与肠-肺轴理论一致。也许,幽门螺杆菌还通过改变胃激素水平、影响自主神经系统和降低热休克蛋白 70 的表达来预防哮喘。来自幽门螺杆菌的治疗产品可能被用于预防和治疗哮喘。本文综述了幽门螺杆菌对过敏性哮喘可能具有的保护作用,以及幽门螺杆菌在治疗哮喘方面的可能应用。